Moberg Pharma AB
Cecilia Ström is a seasoned professional in clinical operations and program leadership with extensive experience in the pharmaceutical industry. Currently serving as Clinical Program Leader at Moberg Pharma AB since October 2022, Cecilia has previously held significant roles including Clinical Operations Lead at ITBMed and Syneos Health at Bristol Myers Squibb. Prior experience includes managing clinical studies at Sobi - Swedish Orphan Biovitrum AB, and leading clinical research as a Clinical Research Manager at Karolinska Trial Alliance. Cecilia's earlier career at AstraZeneca involved various leadership positions, overseeing complex clinical studies and managing teams. Academic credentials include a PhD in Physical Chemistry from Lund University.
This person is not in any teams
Moberg Pharma AB
Moberg Pharma is a rapidly growing Swedish pharmaceutical company that commercializes proprietary, acquired and licensed products in the global market.They create value for patients, physicians and owners by offering products based on proven compounds, which have better efficacy, fewer side effects or are easier to use. Initially, MobergPharma specialized in the treatment of skin diseases but is now widening its scope to include additional areas. They market OTC brands in the U.S. and sell through distributors in more than 35 countries.